Abramson Cancer Center University of Pennsylvania Medical Center

Philadelphia, Pennsylvania 19104

1 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now